EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG

View source ↗

Summary

The European Medicines Agency authorised Usgena, a ustekinumab product from STADA, for treatment of Crohn's disease, psoriasis, psoriatic arthritis, and ulcerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• Usgena (ustekinumab)

Snippet

Status: Authorised. Therapeutic area: Crohn Disease;Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative. MAH: Stada Arzneimittel AG. Decision date: 17/11/2025